Docs
All documentation Fundamental API Live (Delayed) API EOD Historical API Intraday API Real-Time (websockets) API Google Sheets add-on Excel add-on
Community
Academy 134 articles Forum Github 13 repos
Marketplace
Spreadsheets
Google Sheets add-on Excel add-on Wordpress plugin
Pricing
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. F /
  3. 20B.F

BioMark Diagnostics Inc (20B F) stock market data APIs

€0.139 0(0%) as of July 26, 2024
Price chart is built with Anychart

Biomark Diagnostics Inc., an oncology focused company, develops cancer diagnostic solutions to detect, monitor, and assess early treatment. It holds an agreement with National Research Council of Canada Industrial Research Assistance Program to support research and development of liquid biopsy assay for the early detection and screening of lung cancer; and strategic partnership with Rubix LS to develop diagnostic tools to enhance lung cancer screening and improve breast cancer screening program for women with dense breasts. The company was incorporated in 2014 and is headquartered in Richmond, Canada. Biomark Diagnostics Inc. operates as a subsidiary of Biomark Technologies Inc.

BioMark Diagnostics Inc Financial Data Overview

0.139
0.139
-
0.139
0.139
0.105-0.218
16 809 K
90 886 K
163 K
-0.546
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: '20B',
Type: 'Common Stock',
Name: 'BioMark Diagnostics Inc',
Exchange: 'F',
CurrencyCode: 'EUR',
CurrencyName: 'Euro',
CurrencySymbol: '€',
CountryName: 'Germany',
CountryISO: 'DE',
OpenFigi: NULL,
ISIN: 'CA09073K1084',
CIK: NULL,
EmployerIdNumber: NULL,
FiscalYearEnd: 'March',
IPODate: NULL,
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Diagnostics & Research',
}

BioMark Diagnostics Inc Fundamental Data is available in our Financial Data APIs

  • Net Revenue 163 K
  • EBITDA -1 746 988
  • Earnings Per Share -0.01
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get BioMark Diagnostics Inc Earnings via APIs

  • Latest Release NaN
  • EPS/Forecast NaN

Get BioMark Diagnostics Inc End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get BioMark Diagnostics Inc latest news via APIs

BioMark Closes Second Tranche of Private Placement Offering

VANCOUVER, British Columbia, June 24, 2016 (GLOBE NEWSWIRE) -- BioMark Diagnostics Inc. (“BioMark” or the “Company”) (CSE:BUX) (FSE:20B) (OTCQB:BMKDF) is pleased to announce that further to ...
  • BIOMARK DIAGNOSTICS INC
  • OTHER OTC:BMKDF

BioMark Engages Stockhouse.com Deal Room with Private Placement

VANCOUVER, British Columbia, June 20, 2016 (GLOBE NEWSWIRE) -- BioMark Diagnostics Inc. (“BioMark” or the “Company”) (CSE:BUX) (FSE:20B) (OTCQB:BMKDF) is pleased to announce it has engaged S...
  • BIOMARK DIAGNOSTICS INC
  • OTHER OTC:BMKDF
Do you have any questions?
support@eodhistoricaldata.com